Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden
· Delayed Price · Currency is SEK 86.00
-2.90 (-3.26%)
Mar 9, 2026, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.43 billion as of March 9, 2026. Its market cap has decreased by -33.70% in one year.
Market Cap
1.43B
Enterprise Value
1.41B
Revenue
250.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
86.00
Market Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has increased from 1.35B to 1.43B, an increase of 5.95%. That is a compound annual growth rate of 1.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 1.43B | -24.69% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 130.18B |
| Getinge AB | 53.33B |
| Sectra AB | 40.85B |
| Medicover AB | 31.48B |
| Cereno Scientific AB | 1.87B |
| EQL Pharma AB | 1.64B |
| Carasent AB | 1.64B |
| Stille AB | 1.64B |